News

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Five years after the onset of the COVID-19 pandemic, 42 percent of people in the U.S. think federal health agencies are ...
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly ...
Proposed changes to the vaccine approval system deserve the same scrutiny. Press reports indicate that new vaccines will be ...